NCT02165046View on ClinicalTrials.gov

Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

August 31, 2012

Conditions
AsthmaChronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Budesonide

DRUG

Procaterol

Trial Locations (1)

Unknown

Tri-Service General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Intech Biopharm Ltd.

INDUSTRY

NCT02165046 - Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult. | Biotech Hunter | Biotech Hunter